I'm hoping with the start of the new financial year that ACR has loaded all the (bad?) adverse news, financial or otherwise to last year's accounts. The current strategy of developing Generics was started back in 2015. Surly now after 9 years, this is the financial year when the chickens come home to roost. Jet
Ann: Acrux presentation at Hidden Gems in Lifesciences Forum, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $6.931M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.9¢ | 1.7¢ | $8.809K | 495.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 266679 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 252359 | 2 |
View Market Depth
| Last trade - 14.49pm 24/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |